These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6803839)

  • 1. Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency.
    van Diggelen OP; Hoogeveen AT; Smith PJ; Reuser AJ; Galjaard H
    Biochim Biophys Acta; 1982 Apr; 703(1):69-76. PubMed ID: 6803839
    [No Abstract]   [Full Text] [Related]  

  • 2. Correction of combined beta-galactosidase/neuraminidase deficiency in human fibroblasts.
    Hoogeveen A; d'Azzo A; Brossmer R; Galjaard H
    Biochem Biophys Res Commun; 1981 Nov; 103(1):292-300. PubMed ID: 6797429
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoelectron microscopical localization of lysosomal beta-galactosidase and its precursor forms in normal and mutant human fibroblasts.
    Willemsen R; Hoogeveen AT; Sips HJ; van Dongen JM; Galjaard H
    Eur J Cell Biol; 1986 Mar; 40(1):9-15. PubMed ID: 3084261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation, cross correction, and drug correction studies of combined beta-galactosidase neuraminidase deficiency in human fibroblasts.
    Strisciuglio P; Creek KE; Sly WS
    Pediatr Res; 1984 Feb; 18(2):167-71. PubMed ID: 6422434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lysosomal beta-galactosidase properties and the molecular genetics of GM1 gangliosidosis].
    Vel'tishchev IuE; Kalaidzhieva LV
    Vopr Med Khim; 1979; 25(6):709-15. PubMed ID: 117628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between human lysosomal beta-galactosidase and its protective protein.
    Hoogeveen AT; Verheijen FW; Galjaard H
    J Biol Chem; 1983 Oct; 258(20):12143-6. PubMed ID: 6415049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of beta-galactosidase in beta-galactosidase-alpha-neuraminidase deficiency: effects of leupeptin and sucrose.
    Kato T; Okada S; Yutaka T; Yabuuchi H
    Biochem Int; 1983 Feb; 6(2):267-73. PubMed ID: 6433925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective noncompetitive assimilation of bovine testicular beta-galactosidase and bovine liver beta-glucuronidase by generalized gangliosidosis fibroblasts.
    Hieber V; Distler J; Myerowitz R; Schmickel RD; Jourdian GW
    J Clin Invest; 1980 Apr; 65(4):879-84. PubMed ID: 6766954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency.
    Mancini GM; Hoogeveen AT; Galjaard H; Mansson JE; Svennerholm L
    Hum Genet; 1986 May; 73(1):35-8. PubMed ID: 3086209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Galactosidase--neuraminidase deficiency. Deficiency of a freeze-labile neuraminidase in leukocytes and fibroblasts.
    Sakuraba H; Suzuki Y; Fukuoka K; Hayashi K
    J Inherit Metab Dis; 1982; 5(2):79-80. PubMed ID: 6820429
    [No Abstract]   [Full Text] [Related]  

  • 12. Human beta-galactosidases: molecular and clinical aspects.
    Rittmann LS; O'Brien JS
    Isozymes Curr Top Biol Med Res; 1981; 5():77-113. PubMed ID: 6799421
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired degradation of keratan sulfate in GM1-gangliosidosis.
    Yutaka T; Okada S; Kato T; Yabuuchi H
    Clin Chim Acta; 1982 Oct; 125(2):233-40. PubMed ID: 6216030
    [No Abstract]   [Full Text] [Related]  

  • 14. A microassay for acid beta-galactosidase activity toward asialofetuin.
    Mutoh T; Naoi M; Sobue I; Kiuchi K; Nagatsu T
    Clin Chim Acta; 1985 Nov; 152(3):307-14. PubMed ID: 2415273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular heterogeneity in human beta-galactosidase and neuraminidase deficiency.
    Galjaard H; Willemsen R; Hoogeveen AT; Mancini GM; Palmeri S; Verheijen FW; D'Azzo A
    Enzyme; 1987; 38(1-4):132-43. PubMed ID: 3126043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM1-gangliosidosis. Defective recognition site on beta-galactosidase precursor.
    Hoogeveen AT; Reuser AJ; Kroos M; Galjaard H
    J Biol Chem; 1986 May; 261(13):5702-4. PubMed ID: 3084469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of human acid beta-galactosidase].
    Oshima A
    Seikagaku; 1989 Aug; 61(8):713-5. PubMed ID: 2513363
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic beta galactosidase and feline GMI gangliosidosis.
    Barnes IC; Kelly DF; Pennock CA; Randell JA
    Neuropathol Appl Neurobiol; 1981; 7(6):463-76. PubMed ID: 6799849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complementation of beta-galactosidase in fused cells of mucolipidosis II with another variants of beta-galactosidase deficiency using new single cell enzyme assay.
    Okada S; Kato T; Yabuuchi H; Okada Y
    Biochem Biophys Res Commun; 1979 May; 88(2):559-62. PubMed ID: 111672
    [No Abstract]   [Full Text] [Related]  

  • 20. Complementation studies with enucleated fibroblasts from different variants of beta-galactosidase deficiency.
    de Wit-Verbeek HA; Hoogeveen A; Galjaard H
    Exp Cell Res; 1978 Apr; 113(1):215-8. PubMed ID: 416963
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.